Van Hulzen Asset Management, LLC Bristol Myers Squibb CO Transaction History

Van Hulzen Asset Management, LLC

$1.38 Billion
Q3 2024

A detailed history of Van Hulzen Asset Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Van Hulzen Asset Management, LLC holds 14,734 shares of BMY stock, worth $879,177. This represents 0.06% of its overall portfolio holdings.

Number of Shares

14,734

Previous 8,480 73.75%

Holding current value

$879,177

Previous $352,000 116.48%

% of portfolio

0.06%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $248,033 - $323,644	6,254 Added 73.75%	14,734 $762,000
Q2 2024 Aug 07, 2024	BUY	$40.25 - $52.99 $124,251 - $163,580	3,087 Added 57.24%	8,480 $352,000
Q1 2024 May 06, 2024	BUY	$47.98 - $54.4 $959 - $1,088	20 Added 0.37%	5,393 $292,000
Q3 2023 Nov 07, 2023	BUY	$57.89 - $64.73 $7,699 - $8,609	133 Added 2.54%	5,373 $312,000
Q2 2023 Aug 03, 2023	SELL	$63.71 - $70.74 $199,730 - $221,769	-3,135 Reduced 37.43%	5,240 $335,000
Q1 2023 Apr 28, 2023	BUY	$65.71 - $74.53 $77,866 - $88,318	1,185 Added 16.48%	8,375 $580,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $7 - $4,303	-56 Reduced 0.77%	7,190 $511,000
Q2 2022 Aug 04, 2022	SELL	$72.62 - $79.98 $8,714 - $9,597	-120 Reduced 1.63%	7,246 $558,000
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $356,103 - $415,132	-6,640 Reduced 47.41%	7,366 $459,000
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $8,875 - $10,396	-150 Reduced 1.06%	14,006 $829,000
Q2 2021 Aug 06, 2021	BUY	$61.91 - $67.42 $166,537 - $181,359	2,690 Added 23.46%	14,156 $946,000
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $216,828 - $243,867	-3,654 Reduced 24.17%	11,466 $724,000
Q4 2020 Feb 16, 2021	SELL	$57.74 - $65.43 $179,802 - $203,749	-3,114 Reduced 17.08%	15,120 $938,000
Q3 2020 Nov 03, 2020	SELL	$57.43 - $63.64 $14,414 - $15,973	-251 Reduced 1.36%	18,234 $1.1 Million
Q2 2020 Aug 11, 2020	BUY	$54.82 - $64.09 $369,103 - $431,517	6,733 Added 57.29%	18,485 $1.09 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $4,176 - $6,068	90 Added 0.77%	11,752 $655,000
Q4 2019 Feb 12, 2020	SELL	$49.21 - $64.19 $19,536 - $25,483	-397 Reduced 3.29%	11,662 $749,000
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $1.73 Million - $2.05 Million	-40,478 Reduced 77.05%	12,059 $612,000
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $2.12 Million - $2.34 Million	47,423 Added 927.32%	52,537 $2.38 Million
Q1 2019 May 01, 2019	SELL	$45.12 - $53.8 $45,796 - $54,607	-1,015 Reduced 16.56%	5,114 $244,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $1,931 - $2,178	35 Added 0.57%	6,129 $380,000
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $10,863 - $13,540	215 Added 3.66%	6,094 $337,000
Q3 2017 Nov 09, 2017	BUY	$55.23 - $63.74 $55,230 - $63,740	1,000 Added 20.5%	5,879 $375,000
Q2 2017 Aug 14, 2017	BUY	N/A	4,879	4,879 $272,000

Others Institutions Holding BMY

# of Institutions

2,568

Shares Held

1.46B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $127B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Hulzen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Van Hulzen Asset Management, LLC with notifications on news.

Account

Van Hulzen Asset Management, LLC Bristol Myers Squibb CO Transaction History